(1)
Challa, T. R.; Kancharana, M.; Gunupuram, R.; Ejjada, R.; Gunna, H.; Dora, D. A 3% Topical Gel Formulation of Tenofovir Disoproxil Fumarate (TDF) for the Treatment of Human Immunodeficiency Virus (HIV) by Experimental Approach. Curr. Issues Pharm. Med. Sci. 2026, 39 (1), 7-13. https://doi.org/10.12923/cipms-2026-0002.